Genetech Inc. (DNA); Biogen Idec Inc. (BIIB) – Promising Drug Falls Short
The drug Rituxan, which is marketed by both Genetech Inc. (DNA) and partner Biogen Idec Inc. (BIIB), has failed to make any headway in the fight against lupus, a disease affecting the immune system and targeting more than one million Americans each year. There has never been much progress toward a cure, and some felt … Continue reading “Genetech Inc. (DNA); Biogen Idec Inc. (BIIB) – Promising Drug Falls Short”